Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immunoblot, molecular biology, and POC for screening, diagnosis, and prevention. It also provides thermometers, tensiometers, oximetry, hearing protection products, oral and dental hygiene products, self-tests, thermal pads, inhalation chambers, and thermotherapy products, as well as anti-mosquito bracelets and waterproof, moisturizing, and sensitive skin spray. The company was incorporated in 2005 and is based in Illkirch-Graffenstaden, France.
Frequently asked questions
What sector does Biosynex (ALBIO) operate in?
Biosynex belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Biosynex (ALBIO) current stock price?
As of the latest data, Biosynex stock price is €1.00, with a previous close of €1.00.
What is Biosynex (ALBIO) current market capitalization?
Biosynex market cap is approximately 18.43 million.
What is Biosynex (ALBIO) Earnings Per Share (EPS)?
The trailing EPS is -€4.03.
Does Biosynex (ALBIO) pay dividends?
No. Biosynex does not pay a dividend.
What is Biosynex (ALBIO) beta (volatility) score?
Biosynex has a beta of 0.828, meaning its volatility is roughly in line with the market.
